PRKACA antibody (AA 40-310)

Catalog No. ABIN7570948

The Rabbit Polyclonal anti-PRKACA antibody (ABIN7570948) specifically detects PRKACA in WB, ELISA and IHC. The antibody is reactive with Human samples.

Quick Overview for PRKACA antibody (AA 40-310) (ABIN7570948)

Target: PRKACA (Protein Kinase A, alpha (PRKACA))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This PRKACA antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Product Details anti-PRKACA Antibody

Binding Specificity: AA 40-310

Purpose: Anti-Human PRKACA Polyclonal Antibody

Purification: Antigen affinity purification.

Immunogen: E. coli - derived recombinant Human PRKACA (His40-Lys310).

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.

Target Details for PRKACA

Target: PRKACA (Protein Kinase A, alpha (PRKACA))

Alternative Name: PRKACA

Background: PRKACA, PKACA, PKA C-alpha, cAMP-dependent protein kinase catalytic subunit alpha

UniProt: P17612

Pathways: NF-kappaB Signaling, Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection